Your browser doesn't support javascript.
loading
Hospital-Wide Surveillance of Fracture Risk Assessment by Both FRAX and Medication Patterns in Acute Care Hospital.
Tobe, Takao; Kubo, Misaki; Toda, Takahiro; Morita, Mitsuhiro; Watanabe, Mika; Yamada, Shigeki; Suzuki, Atsushi; Hayashi, Takahiro.
Afiliación
  • Tobe T; College of Pharmacy, Kinjo Gakuin University.
  • Kubo M; Department of Clinical Pharmacy, Fujita Health University.
  • Toda T; Department of Clinical Pharmacy, Fujita Health University.
  • Morita M; Department of Clinical Pharmacy, Fujita Health University.
  • Watanabe M; Department of Orthopedic Surgery, Fujita Health University.
  • Yamada S; College of Pharmacy, Kinjo Gakuin University.
  • Suzuki A; Department of Clinical Pharmacy, Fujita Health University.
  • Hayashi T; Department of Endocrinology and Metabolism, Fujita Health University.
Biol Pharm Bull ; 45(7): 881-887, 2022 Jul 01.
Article en En | MEDLINE | ID: mdl-35474184
ABSTRACT
To identify patients at a high risk for primary and secondary osteoporotic fractures using fracture risk assessments performed using the current method and the proposed method, in an acute care hospital and to identify departments where high-risk patients are admitted. This retrospective study included patients aged 40-90 years who were hospitalized at Fujita Health University Hospital. We collated the clinical data and prescriptions of all study participants. We also gathered data pertaining to risk factors according to Fracture Risk Assessment Tool (FRAX). Of the 1595 patients, the mean number of major osteoporotic fracture risk predicted using FRAX was 11.73%. The department of rheumatology showed the highest fracture risk (18.55 ± 16.81) and had the highest number of patients on medications that resulted in reduced bone mineral density (1.07 ± 0.98 medication). Based on the FRAX, the proportion of patients in the high-risk group in this department was significantly higher compared with those in the remaining departments with respect to glucocorticoid administration, rheumatoid arthritis, and secondary osteoporosis. However, the departments included in the high-risk group were not necessarily the same as the departments included in the top group, based on the administered medications. FRAX score is calculated based on various risk factors; however, only glucocorticoid corresponds to medications. We should focus on medication prescription patterns in addition to FRAX to improve fracture risk assessment in hospital-wide surveillance. Therefore, we recommend the use of FRAX along with the prescribed medications to identify departments that admit high-risk patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Densidad Ósea / Fracturas Osteoporóticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Densidad Ósea / Fracturas Osteoporóticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2022 Tipo del documento: Article